Market closed · data as of 27 Aug 2026 · source NSE via Alphave. Open the live chart →
Metropolis Healthcare is a pan-India diagnostics chain offering pathology and clinical laboratory testing, from routine biochemistry and haematology to specialised tests in oncology, genomics and infectious disease. It operates through a hub-and-spoke network of central and satellite laboratories, patient service centres and third-party pickup points, serving individual patients, hospitals, clinics and corporates. Specialised and wellness testing carry higher realisations and are key margin drivers, with core strength in western and southern India.
It is one of India's largest organised diagnostics chains alongside Dr Lal PathLabs and Vijaya Diagnostic.
Metropolis Healthcare Ltd. is a constituent of NIFTY MICROCAP 250. See where it sits on the market heatmap →
Consolidated annual figures taken from Metropolis Healthcare Ltd.'s own filed statements — not estimates, and not restated by us. The most recent period shown is FY26 (year ended 31 Mar 2026).
Per-share figures are not restated. Shares outstanding changed from 5.18 crore to 20.73 crore in FY26, consistent with a bonus issue or stock split. Each year's EPS and book value below are as that year was filed, on that year's share count — so the per-share line falls across FY26 even where profit did not. Compare the absolute figures (EBITDA, free cash flow, total debt) and the margins across that boundary, not the per-share ones.
| Metric | FY26 | FY25 | FY24 |
|---|---|---|---|
| EPS (basic, ₹) | 9.19 | 28.29 | 24.95 |
| Book value / share (₹) | 73.53 | 257.65 | 214.59 |
| Return on equity | 12.5% | 10.9% | 11.6% |
| Return on capital employed | 14.8% | 12.3% | 14.4% |
| Operating margin | 16.2% | 14.6% | 15.6% |
| Net margin | 11.6% | 10.9% | 10.6% |
| EBITDA | ₹401 Cr | ₹303 Cr | ₹283 Cr |
| Free cash flow | ₹315 Cr | ₹194 Cr | ₹200 Cr |
| Total debt | ₹19 Cr | ₹14 Cr | ₹0 Cr |
| Debt to equity | 0.01 | 0.01 | 0.00 |
| Interest coverage | 10.9 | 10.5 | 8.3 |
| Current ratio | 1.40 | 1.18 | 1.28 |
| Shares outstanding | 20,73,28,500 | 5,18,00,500 | 5,12,27,000 |
Open the full income statement, balance sheet and cash flow for METROPOLIS →
As disclosed for the quarter ended 30 Jun 2026.
Institutional ownership changes quarter to quarter. See daily FII and DII flows across the market →
Companies Alphave classifies in the same sub-sector, closest by market capitalisation.